Advertisement

Topics

STAT Plus: Omeros defends its drug, but still won’t answer basic questions

13:04 EDT 23 Aug 2017 | STAT

Omeros sought to defend its experimental drug OMS721 with a press release responding to my questions about the drug. But it didn't clear much up.

Original Article: STAT Plus: Omeros defends its drug, but still won’t answer basic questions

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Omeros defends its drug, but still won’t answer basic questions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...